MAIA Biotechnology Inc (MAIA)

2.02 -0.02 (-0.98%) USD  |  NYAM  |  Dec 20, 16:00
2.01 -0.01 (-0.50%) After-Hours: 20:00
More

MAIA Biotechnology Enterprise Value: 42.48M for Dec. 20, 2024

Enterprise Value Chart

View Enterprise Value for MAIA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Emergent BioSolutions Inc 951.59M
Regeneron Pharmaceuticals Inc 69.31B
Aspira Womens Health Inc 12.60M
Catalent Inc 16.12B
NovaBay Pharmaceuticals Inc 1.870M

Enterprise Value Related Metrics

Net Income (Quarterly) -2.736M
Total Expenses (Quarterly) 4.173M
EPS Diluted (Quarterly) -0.11
Earnings Yield -68.32%